| 1 | MRNAOpen MRNA on Seeking Alpha in a new tab.80% of the way from the 52-week low to the 52-week high. | ModernaHealthcare·Biotechnology | 100 | 4Quality: 4th percentile | 100Momentum: 100th percentile | 0Growth: 0th percentile | 3Valuation: 3rd percentile | 32Expectations: 32nd percentile | QQuality4Quality: 4th percentileMMomentum100Momentum: 100th percentileGGrowth0Growth: 0th percentileVValuation3Valuation: 3rd percentileEExpectations32Expectations: 32nd percentile |
| 2 | TXGOpen TXG on Seeking Alpha in a new tab.73% of the way from the 52-week low to the 52-week high. | 10x GenomicsHealthcare·Biotechnology | 100 | 79Quality: 79th percentile | 99Momentum: 99th percentile | 4Growth: 4th percentile | 7Valuation: 7th percentile | 93Expectations: 93rd percentile | QQuality79Quality: 79th percentileMMomentum99Momentum: 99th percentileGGrowth4Growth: 4th percentileVValuation7Valuation: 7th percentileEExpectations93Expectations: 93rd percentile |
| 3 | TWSTOpen TWST on Seeking Alpha in a new tab.70% of the way from the 52-week low to the 52-week high. | Twist BioscienceHealthcare·Biotechnology | 100 | 44Quality: 44th percentile | 99Momentum: 99th percentile | 47Growth: 47th percentile | 3Valuation: 3rd percentile | 6Expectations: 6th percentile | QQuality44Quality: 44th percentileMMomentum99Momentum: 99th percentileGGrowth47Growth: 47th percentileVValuation3Valuation: 3rd percentileEExpectations6Expectations: 6th percentile |
| 12 | ILMNOpen ILMN on Seeking Alpha in a new tab.86% of the way from the 52-week low to the 52-week high. | IlluminaHealthcare·Medical - Diagnostics & Research | 98 | 26Quality: 26th percentile | 98Momentum: 98th percentile | 3Growth: 3rd percentile | 12Valuation: 12th percentile | 54Expectations: 54th percentile | QQuality26Quality: 26th percentileMMomentum98Momentum: 98th percentileGGrowth3Growth: 3rd percentileVValuation12Valuation: 12th percentileEExpectations54Expectations: 54th percentile |
| 13 | GHOpen GH on Seeking Alpha in a new tab.89% of the way from the 52-week low to the 52-week high. | Guardant HealthHealthcare·Medical - Diagnostics & Research | 98 | –No data | 98Momentum: 98th percentile | 74Growth: 74th percentile | 2Valuation: 2nd percentile | 4Expectations: 4th percentile | QQuality–No dataMMomentum98Momentum: 98th percentileGGrowth74Growth: 74th percentileVValuation2Valuation: 2nd percentileEExpectations4Expectations: 4th percentile |
| 16 | NTRAOpen NTRA on Seeking Alpha in a new tab.90% of the way from the 52-week low to the 52-week high. | NateraHealthcare·Medical - Diagnostics & Research | 98 | 95Quality: 95th percentile | 97Momentum: 97th percentile | 16Growth: 16th percentile | 3Valuation: 3rd percentile | 45Expectations: 45th percentile | QQuality95Quality: 95th percentileMMomentum97Momentum: 97th percentileGGrowth16Growth: 16th percentileVValuation3Valuation: 3rd percentileEExpectations45Expectations: 45th percentile |
| 21 | AVTROpen AVTR on Seeking Alpha in a new tab.97% of the way from the 52-week low to the 52-week high. | AvantorHealthcare·Medical - Instruments & Supplies | 97 | 19Quality: 19th percentile | 97Momentum: 97th percentile | 6Growth: 6th percentile | 55Valuation: 55th percentile | 65Expectations: 65th percentile | QQuality19Quality: 19th percentileMMomentum97Momentum: 97th percentileGGrowth6Growth: 6th percentileVValuation55Valuation: 55th percentileEExpectations65Expectations: 65th percentile |
| 28 | RVTYOpen RVTY on Seeking Alpha in a new tab.95% of the way from the 52-week low to the 52-week high. | RevvityHealthcare·Medical - Diagnostics & Research | 96 | 29Quality: 29th percentile | 96Momentum: 96th percentile | 14Growth: 14th percentile | 43Valuation: 43rd percentile | 79Expectations: 79th percentile | QQuality29Quality: 29th percentileMMomentum96Momentum: 96th percentileGGrowth14Growth: 14th percentileVValuation43Valuation: 43rd percentileEExpectations79Expectations: 79th percentile |
| 29 | HALOOpen HALO on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high. | Halozyme TherapeuticsHealthcare·Biotechnology | 96 | 27Quality: 27th percentile | 96Momentum: 96th percentile | 47Growth: 47th percentile | 28Valuation: 28th percentile | 89Expectations: 89th percentile | QQuality27Quality: 27th percentileMMomentum96Momentum: 96th percentileGGrowth47Growth: 47th percentileVValuation28Valuation: 28th percentileEExpectations89Expectations: 89th percentile |
| 31 | CRLOpen CRL on Seeking Alpha in a new tab.100% of the way from the 52-week low to the 52-week high. | Charles River Laboratories InternationalHealthcare·Medical - Diagnostics & Research | 96 | 33Quality: 33rd percentile | 95Momentum: 95th percentile | 15Growth: 15th percentile | 25Valuation: 25th percentile | 67Expectations: 67th percentile | QQuality33Quality: 33rd percentileMMomentum95Momentum: 95th percentileGGrowth15Growth: 15th percentileVValuation25Valuation: 25th percentileEExpectations67Expectations: 67th percentile |
| 35 | IQVOpen IQV on Seeking Alpha in a new tab.90% of the way from the 52-week low to the 52-week high. | IQVIAHealthcare·Medical - Diagnostics & Research | 95 | 25Quality: 25th percentile | 95Momentum: 95th percentile | 35Growth: 35th percentile | 53Valuation: 53rd percentile | 40Expectations: 40th percentile | QQuality25Quality: 25th percentileMMomentum95Momentum: 95th percentileGGrowth35Growth: 35th percentileVValuation53Valuation: 53rd percentileEExpectations40Expectations: 40th percentile |
| 36 | HUMOpen HUM on Seeking Alpha in a new tab.86% of the way from the 52-week low to the 52-week high. | HumanaHealthcare·Medical - Healthcare Plans | 95 | 93Quality: 93rd percentile | 95Momentum: 95th percentile | 10Growth: 10th percentile | 76Valuation: 76th percentile | 44Expectations: 44th percentile | QQuality93Quality: 93rd percentileMMomentum95Momentum: 95th percentileGGrowth10Growth: 10th percentileVValuation76Valuation: 76th percentileEExpectations44Expectations: 44th percentile |
| 40 | TEMOpen TEM on Seeking Alpha in a new tab.60% of the way from the 52-week low to the 52-week high. | Tempus AIHealthcare·Medical - Healthcare Information Services | 94 | 85Quality: 85th percentile | 94Momentum: 94th percentile | 8Growth: 8th percentile | 3Valuation: 3rd percentile | 96Expectations: 96th percentile | QQuality85Quality: 85th percentileMMomentum94Momentum: 94th percentileGGrowth8Growth: 8th percentileVValuation3Valuation: 3rd percentileEExpectations96Expectations: 96th percentile |
| 52 | AOpen A on Seeking Alpha in a new tab.98% of the way from the 52-week low to the 52-week high. | Agilent TechnologiesHealthcare·Medical - Diagnostics & Research | 93 | 47Quality: 47th percentile | 92Momentum: 92nd percentile | 56Growth: 56th percentile | 27Valuation: 27th percentile | 62Expectations: 62nd percentile | QQuality47Quality: 47th percentileMMomentum92Momentum: 92nd percentileGGrowth56Growth: 56th percentileVValuation27Valuation: 27th percentileEExpectations62Expectations: 62nd percentile |
| 53 | MEDPOpen MEDP on Seeking Alpha in a new tab.97% of the way from the 52-week low to the 52-week high. | MedpaceHealthcare·Medical - Diagnostics & Research | 93 | 55Quality: 55th percentile | 92Momentum: 92nd percentile | 48Growth: 48th percentile | 23Valuation: 23rd percentile | 63Expectations: 63rd percentile | QQuality55Quality: 55th percentileMMomentum92Momentum: 92nd percentileGGrowth48Growth: 48th percentileVValuation23Valuation: 23rd percentileEExpectations63Expectations: 63rd percentile |
| 55 | WATOpen WAT on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high. | WatersHealthcare·Medical - Diagnostics & Research | 92 | 7Quality: 7th percentile | 92Momentum: 92nd percentile | 48Growth: 48th percentile | 21Valuation: 21st percentile | 23Expectations: 23rd percentile | QQuality7Quality: 7th percentileMMomentum92Momentum: 92nd percentileGGrowth48Growth: 48th percentileVValuation21Valuation: 21st percentileEExpectations23Expectations: 23rd percentile |
| 58 | DXCMOpen DXCM on Seeking Alpha in a new tab.64% of the way from the 52-week low to the 52-week high. | DexComHealthcare·Medical - Devices | 92 | 82Quality: 82nd percentile | 91Momentum: 91st percentile | 86Growth: 86th percentile | 42Valuation: 42nd percentile | 76Expectations: 76th percentile | QQuality82Quality: 82nd percentileMMomentum91Momentum: 91st percentileGGrowth86Growth: 86th percentileVValuation42Valuation: 42nd percentileEExpectations76Expectations: 76th percentile |
| 59 | THCOpen THC on Seeking Alpha in a new tab.83% of the way from the 52-week low to the 52-week high. | Tenet HealthcareHealthcare·Medical - Care Facilities | 92 | 67Quality: 67th percentile | 91Momentum: 91st percentile | 82Growth: 82nd percentile | 93Valuation: 93rd percentile | 94Expectations: 94th percentile | QQuality67Quality: 67th percentileMMomentum91Momentum: 91st percentileGGrowth82Growth: 82nd percentileVValuation93Valuation: 93rd percentileEExpectations94Expectations: 94th percentile |
| 62 | TMOOpen TMO on Seeking Alpha in a new tab.95% of the way from the 52-week low to the 52-week high. | Thermo Fisher ScientificHealthcare·Medical - Diagnostics & Research | 91 | 36Quality: 36th percentile | 91Momentum: 91st percentile | 57Growth: 57th percentile | 37Valuation: 37th percentile | 42Expectations: 42nd percentile | QQuality36Quality: 36th percentileMMomentum91Momentum: 91st percentileGGrowth57Growth: 57th percentileVValuation37Valuation: 37th percentileEExpectations42Expectations: 42nd percentile |
| 68 | RVMDOpen RVMD on Seeking Alpha in a new tab.77% of the way from the 52-week low to the 52-week high. | Revolution MedicinesHealthcare·Biotechnology | 90 | –No data | 90Momentum: 90th percentile | 15Growth: 15th percentile | 2Valuation: 2nd percentile | 1Expectations: 1st percentile | QQuality–No dataMMomentum90Momentum: 90th percentileGGrowth15Growth: 15th percentileVValuation2Valuation: 2nd percentileEExpectations1Expectations: 1st percentile |
| 70 | MRKOpen MRK on Seeking Alpha in a new tab.81% of the way from the 52-week low to the 52-week high. | Merck & Co.Healthcare·Drug Manufacturers - General | 90 | 16Quality: 16th percentile | 90Momentum: 90th percentile | 7Growth: 7th percentile | 36Valuation: 36th percentile | 95Expectations: 95th percentile | QQuality16Quality: 16th percentileMMomentum90Momentum: 90th percentileGGrowth7Growth: 7th percentileVValuation36Valuation: 36th percentileEExpectations95Expectations: 95th percentile |
| 71 | LLYOpen LLY on Seeking Alpha in a new tab.92% of the way from the 52-week low to the 52-week high. | Eli Lilly and CompanyHealthcare·Drug Manufacturers - General | 90 | 66Quality: 66th percentile | 90Momentum: 90th percentile | 93Growth: 93rd percentile | 9Valuation: 9th percentile | 90Expectations: 90th percentile | QQuality66Quality: 66th percentileMMomentum90Momentum: 90th percentileGGrowth93Growth: 93rd percentileVValuation9Valuation: 9th percentileEExpectations90Expectations: 90th percentile |
| 73 | TECHOpen TECH on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high. | Bio-TechneHealthcare·Biotechnology | 90 | 86Quality: 86th percentile | 89Momentum: 89th percentile | 92Growth: 92nd percentile | 20Valuation: 20th percentile | 17Expectations: 17th percentile | QQuality86Quality: 86th percentileMMomentum89Momentum: 89th percentileGGrowth92Growth: 92nd percentileVValuation20Valuation: 20th percentileEExpectations17Expectations: 17th percentile |
| 74 | ABBVOpen ABBV on Seeking Alpha in a new tab.95% of the way from the 52-week low to the 52-week high. | AbbVieHealthcare·Drug Manufacturers - General | 90 | –No data | 89Momentum: 89th percentile | 77Growth: 77th percentile | 30Valuation: 30th percentile | 22Expectations: 22nd percentile | QQuality–No dataMMomentum89Momentum: 89th percentileGGrowth77Growth: 77th percentileVValuation30Valuation: 30th percentileEExpectations22Expectations: 22nd percentile |
| 78 | SOLVOpen SOLV on Seeking Alpha in a new tab.65% of the way from the 52-week low to the 52-week high. | SolventumHealthcare·Medical - Instruments & Supplies | 89 | 54Quality: 54th percentile | 89Momentum: 89th percentile | 92Growth: 92nd percentile | 67Valuation: 67th percentile | 91Expectations: 91st percentile | QQuality54Quality: 54th percentileMMomentum89Momentum: 89th percentileGGrowth92Growth: 92nd percentileVValuation67Valuation: 67th percentileEExpectations91Expectations: 91st percentile |
| 79 | BAXOpen BAX on Seeking Alpha in a new tab.64% of the way from the 52-week low to the 52-week high. | Baxter InternationalHealthcare·Medical - Instruments & Supplies | 89 | 34Quality: 34th percentile | 88Momentum: 88th percentile | 28Growth: 28th percentile | 66Valuation: 66th percentile | 95Expectations: 95th percentile | QQuality34Quality: 34th percentileMMomentum88Momentum: 88th percentileGGrowth28Growth: 28th percentileVValuation66Valuation: 66th percentileEExpectations95Expectations: 95th percentile |
| 81 | EXELOpen EXEL on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high. | ExelixisHealthcare·Biotechnology | 89 | 96Quality: 96th percentile | 88Momentum: 88th percentile | 26Growth: 26th percentile | 57Valuation: 57th percentile | 55Expectations: 55th percentile | QQuality96Quality: 96th percentileMMomentum88Momentum: 88th percentileGGrowth26Growth: 26th percentileVValuation57Valuation: 57th percentileEExpectations55Expectations: 55th percentile |
| 85 | WSTOpen WST on Seeking Alpha in a new tab.100% of the way from the 52-week low to the 52-week high. | West Pharmaceutical ServicesHealthcare·Medical - Instruments & Supplies | 88 | 77Quality: 77th percentile | 88Momentum: 88th percentile | 56Growth: 56th percentile | 15Valuation: 15th percentile | 75Expectations: 75th percentile | QQuality77Quality: 77th percentileMMomentum88Momentum: 88th percentileGGrowth56Growth: 56th percentileVValuation15Valuation: 15th percentileEExpectations75Expectations: 75th percentile |
| 89 | INCYOpen INCY on Seeking Alpha in a new tab.67% of the way from the 52-week low to the 52-week high. | IncyteHealthcare·Biotechnology | 87 | 62Quality: 62nd percentile | 87Momentum: 87th percentile | 9Growth: 9th percentile | 82Valuation: 82nd percentile | 94Expectations: 94th percentile | QQuality62Quality: 62nd percentileMMomentum87Momentum: 87th percentileGGrowth9Growth: 9th percentileVValuation82Valuation: 82nd percentileEExpectations94Expectations: 94th percentile |
| 93 | DHROpen DHR on Seeking Alpha in a new tab.88% of the way from the 52-week low to the 52-week high. | DanaherHealthcare·Medical - Diagnostics & Research | 87 | 28Quality: 28th percentile | 86Momentum: 86th percentile | 58Growth: 58th percentile | 40Valuation: 40th percentile | 66Expectations: 66th percentile | QQuality28Quality: 28th percentileMMomentum86Momentum: 86th percentileGGrowth58Growth: 58th percentileVValuation40Valuation: 40th percentileEExpectations66Expectations: 66th percentile |
| 97 | CNCOpen CNC on Seeking Alpha in a new tab.91% of the way from the 52-week low to the 52-week high. | CenteneHealthcare·Medical - Healthcare Plans | 86 | 87Quality: 87th percentile | 86Momentum: 86th percentile | 54Growth: 54th percentile | 84Valuation: 84th percentile | 98Expectations: 98th percentile | QQuality87Quality: 87th percentileMMomentum86Momentum: 86th percentileGGrowth54Growth: 54th percentileVValuation84Valuation: 84th percentileEExpectations98Expectations: 98th percentile |
| 107 | VTRSOpen VTRS on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high. | ViatrisHealthcare·Drug Manufacturers - Specialty & Generic | 85 | 67Quality: 67th percentile | 84Momentum: 84th percentile | 83Growth: 83rd percentile | 79Valuation: 79th percentile | 76Expectations: 76th percentile | QQuality67Quality: 67th percentileMMomentum84Momentum: 84th percentileGGrowth83Growth: 83rd percentileVValuation79Valuation: 79th percentileEExpectations76Expectations: 76th percentile |
| 109 | AMGNOpen AMGN on Seeking Alpha in a new tab.98% of the way from the 52-week low to the 52-week high. | AmgenHealthcare·Drug Manufacturers - General | 85 | 60Quality: 60th percentile | 84Momentum: 84th percentile | 60Growth: 60th percentile | 35Valuation: 35th percentile | 71Expectations: 71st percentile | QQuality60Quality: 60th percentileMMomentum84Momentum: 84th percentileGGrowth60Growth: 60th percentileVValuation35Valuation: 35th percentileEExpectations71Expectations: 71st percentile |
| 110 | BIIBOpen BIIB on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high. | BiogenHealthcare·Drug Manufacturers - General | 84 | 15Quality: 15th percentile | 84Momentum: 84th percentile | 7Growth: 7th percentile | 69Valuation: 69th percentile | 85Expectations: 85th percentile | QQuality15Quality: 15th percentileMMomentum84Momentum: 84th percentileGGrowth7Growth: 7th percentileVValuation69Valuation: 69th percentileEExpectations85Expectations: 85th percentile |
| 111 | BDXOpen BDX on Seeking Alpha in a new tab.93% of the way from the 52-week low to the 52-week high. | Becton, Dickinson and CompanyHealthcare·Medical - Instruments & Supplies | 84 | 19Quality: 19th percentile | 84Momentum: 84th percentile | 25Growth: 25th percentile | 64Valuation: 64th percentile | 31Expectations: 31st percentile | QQuality19Quality: 19th percentileMMomentum84Momentum: 84th percentileGGrowth25Growth: 25th percentileVValuation64Valuation: 64th percentileEExpectations31Expectations: 31st percentile |
| 123 | VRTXOpen VRTX on Seeking Alpha in a new tab.75% of the way from the 52-week low to the 52-week high. | Vertex PharmaceuticalsHealthcare·Biotechnology | 83 | 58Quality: 58th percentile | 82Momentum: 82nd percentile | 1Growth: 1st percentile | 28Valuation: 28th percentile | 15Expectations: 15th percentile | QQuality58Quality: 58th percentileMMomentum82Momentum: 82nd percentileGGrowth1Growth: 1st percentileVValuation28Valuation: 28th percentileEExpectations15Expectations: 15th percentile |
| 125 | MTDOpen MTD on Seeking Alpha in a new tab.96% of the way from the 52-week low to the 52-week high. | Mettler-Toledo InternationalHealthcare·Medical - Diagnostics & Research | 82 | –No data | 82Momentum: 82nd percentile | 36Growth: 36th percentile | 14Valuation: 14th percentile | 49Expectations: 49th percentile | QQuality–No dataMMomentum82Momentum: 82nd percentileGGrowth36Growth: 36th percentileVValuation14Valuation: 14th percentileEExpectations49Expectations: 49th percentile |
| 127 | DGXOpen DGX on Seeking Alpha in a new tab.93% of the way from the 52-week low to the 52-week high. | Quest DiagnosticsHealthcare·Medical - Diagnostics & Research | 82 | 53Quality: 53rd percentile | 82Momentum: 82nd percentile | 31Growth: 31st percentile | 74Valuation: 74th percentile | 43Expectations: 43rd percentile | QQuality53Quality: 53rd percentileMMomentum82Momentum: 82nd percentileGGrowth31Growth: 31st percentileVValuation74Valuation: 74th percentileEExpectations43Expectations: 43rd percentile |
| 128 | EHCOpen EHC on Seeking Alpha in a new tab.78% of the way from the 52-week low to the 52-week high. | Encompass HealthHealthcare·Medical - Care Facilities | 82 | 43Quality: 43rd percentile | 81Momentum: 81st percentile | 38Growth: 38th percentile | 68Valuation: 68th percentile | 45Expectations: 45th percentile | QQuality43Quality: 43rd percentileMMomentum81Momentum: 81st percentileGGrowth38Growth: 38th percentileVValuation68Valuation: 68th percentileEExpectations45Expectations: 45th percentile |
| 131 | JNJOpen JNJ on Seeking Alpha in a new tab.88% of the way from the 52-week low to the 52-week high. | Johnson & JohnsonHealthcare·Drug Manufacturers - General | 81 | 46Quality: 46th percentile | 81Momentum: 81st percentile | 41Growth: 41st percentile | 35Valuation: 35th percentile | 31Expectations: 31st percentile | QQuality46Quality: 46th percentileMMomentum81Momentum: 81st percentileGGrowth41Growth: 41st percentileVValuation35Valuation: 35th percentileEExpectations31Expectations: 31st percentile |
| 135 | LHOpen LH on Seeking Alpha in a new tab.90% of the way from the 52-week low to the 52-week high. | LabcorpHealthcare·Medical - Diagnostics & Research | 81 | 65Quality: 65th percentile | 80Momentum: 80th percentile | 23Growth: 23rd percentile | 67Valuation: 67th percentile | 42Expectations: 42nd percentile | QQuality65Quality: 65th percentileMMomentum80Momentum: 80th percentileGGrowth23Growth: 23rd percentileVValuation67Valuation: 67th percentileEExpectations42Expectations: 42nd percentile |
| 140 | GILDOpen GILD on Seeking Alpha in a new tab.97% of the way from the 52-week low to the 52-week high. | Gilead SciencesHealthcare·Drug Manufacturers - General | 80 | 16Quality: 16th percentile | 80Momentum: 80th percentile | 8Growth: 8th percentile | 31Valuation: 31st percentile | 56Expectations: 56th percentile | QQuality16Quality: 16th percentileMMomentum80Momentum: 80th percentileGGrowth8Growth: 8th percentileVValuation31Valuation: 31st percentileEExpectations56Expectations: 56th percentile |
| 143 | BTSGOpen BTSG on Seeking Alpha in a new tab.64% of the way from the 52-week low to the 52-week high. | BrightSpring Health ServicesHealthcare·Medical - Healthcare Information Services | 80 | 99Quality: 99th percentile | 79Momentum: 79th percentile | 0Growth: 0th percentile | 54Valuation: 54th percentile | 74Expectations: 74th percentile | QQuality99Quality: 99th percentileMMomentum79Momentum: 79th percentileGGrowth0Growth: 0th percentileVValuation54Valuation: 54th percentileEExpectations74Expectations: 74th percentile |
| 144 | RPRXOpen RPRX on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high. | Royalty PharmaHealthcare·Medical - Pharmaceuticals | 80 | 4Quality: 4th percentile | 79Momentum: 79th percentile | 18Growth: 18th percentile | 55Valuation: 55th percentile | 39Expectations: 39th percentile | QQuality4Quality: 4th percentileMMomentum79Momentum: 79th percentileGGrowth18Growth: 18th percentileVValuation55Valuation: 55th percentileEExpectations39Expectations: 39th percentile |
| 145 | DVAOpen DVA on Seeking Alpha in a new tab.55% of the way from the 52-week low to the 52-week high. | DaVitaHealthcare·Medical - Care Facilities | 79 | –No data | 79Momentum: 79th percentile | 40Growth: 40th percentile | 98Valuation: 98th percentile | 38Expectations: 38th percentile | QQuality–No dataMMomentum79Momentum: 79th percentileGGrowth40Growth: 40th percentileVValuation98Valuation: 98th percentileEExpectations38Expectations: 38th percentile |
| 193 | PFEOpen PFE on Seeking Alpha in a new tab.92% of the way from the 52-week low to the 52-week high. | PfizerHealthcare·Drug Manufacturers - General | 73 | –No data | 72Momentum: 72nd percentile | 1Growth: 1st percentile | 90Valuation: 90th percentile | 73Expectations: 73rd percentile | QQuality–No dataMMomentum72Momentum: 72nd percentileGGrowth1Growth: 1st percentileVValuation90Valuation: 90th percentileEExpectations73Expectations: 73rd percentile |
| 200 | BMRNOpen BMRN on Seeking Alpha in a new tab.28% of the way from the 52-week low to the 52-week high. | BioMarin PharmaceuticalHealthcare·Biotechnology | 72 | 13Quality: 13th percentile | 71Momentum: 71st percentile | 0Growth: 0th percentile | 68Valuation: 68th percentile | 89Expectations: 89th percentile | QQuality13Quality: 13th percentileMMomentum71Momentum: 71st percentileGGrowth0Growth: 0th percentileVValuation68Valuation: 68th percentileEExpectations89Expectations: 89th percentile |
| 203 | MDTOpen MDT on Seeking Alpha in a new tab.71% of the way from the 52-week low to the 52-week high. | MedtronicHealthcare·Medical - Devices | 71 | 45Quality: 45th percentile | 71Momentum: 71st percentile | 51Growth: 51st percentile | 73Valuation: 73rd percentile | 42Expectations: 42nd percentile | QQuality45Quality: 45th percentileMMomentum71Momentum: 71st percentileGGrowth51Growth: 51st percentileVValuation73Valuation: 73rd percentileEExpectations42Expectations: 42nd percentile |
| 205 | ZBHOpen ZBH on Seeking Alpha in a new tab.73% of the way from the 52-week low to the 52-week high. | Zimmer BiometHealthcare·Medical - Devices | 71 | 32Quality: 32nd percentile | 70Momentum: 70th percentile | 20Growth: 20th percentile | 93Valuation: 93rd percentile | 33Expectations: 33rd percentile | QQuality32Quality: 32nd percentileMMomentum70Momentum: 70th percentileGGrowth20Growth: 20th percentileVValuation93Valuation: 93rd percentileEExpectations33Expectations: 33rd percentile |
| 206 | BMYOpen BMY on Seeking Alpha in a new tab.77% of the way from the 52-week low to the 52-week high. | Bristol-Myers SquibbHealthcare·Drug Manufacturers - General | 71 | 57Quality: 57th percentile | 70Momentum: 70th percentile | 24Growth: 24th percentile | 83Valuation: 83rd percentile | 89Expectations: 89th percentile | QQuality57Quality: 57th percentileMMomentum70Momentum: 70th percentileGGrowth24Growth: 24th percentileVValuation83Valuation: 83rd percentileEExpectations89Expectations: 89th percentile |